Company Filing History:
2 out of 15,475 
1 out of 2,930 
1 out of 1 Years Active: 1996-2000
Title: Katalin Kalman: Innovator in Potassium Channel Research
Introduction
Katalin Kalman is a prominent inventor based in Irvine, California. She has made significant contributions to the field of biotechnology, particularly in the study of potassium channels and their applications in medical therapeutics. With a total of 2 patents, her work has the potential to impact the treatment of various health conditions.
Latest Patents
Katalin Kalman's latest patents include innovative compositions and methods related to the ShK toxin. The first patent discloses methods and compositions comprising DNA segments and proteins derived from sea anemone species. This includes the novel ShK toxin, its analogs, and chemically-modified variants, along with various applications for these DNA segments in diagnostics and protein production. The second patent focuses on the identification of a new voltage-gated potassium channel gene, Kv1.7, expressed in pancreatic beta-cells. This invention aims to develop therapeutics for non-insulin-dependent diabetes mellitus by identifying materials that can modulate this channel.
Career Highlights
Throughout her career, Katalin has worked with esteemed institutions such as the University of California and the University of Florida Research Foundation. Her research has been pivotal in advancing our understanding of potassium channels and their role in human health.
Collaborations
Katalin has collaborated with notable individuals in her field, including William Reade Kem and Michael William Pennington. These partnerships have further enriched her research and contributed to her innovative work.
Conclusion
Katalin Kalman is a trailblazer in the field of potassium channel research, with her patents paving the way for new therapeutic approaches. Her contributions continue to influence the scientific community and hold promise for future medical advancements.